Back to today’s briefing

Story perspectives

Kailera Therapeutics Raises $625M in Record Biotech IPO

4/17/2026

23 4 Full Breakdown

Summary

Story summary

Kailera Therapeutics, a Waltham, Massachusetts-based company, raised $625 million in a record IPO by selling 39 million shares at $16 per share.
The offering was the largest biotech IPO, surpassing Moderna's previous record.
Proceeds will fund Kailera's obesity pipeline, including ribupatide in Phase 3.
CEO Ron Renaud said the company will focus on executing its strategy.
The IPO signals a resurgence in biotech listings after a brief slowdown.

1 of 1

Story summary

Kailera Therapeutics, a Waltham, Massachusetts-based company, raised $625 million in a record IPO by selling 39 million shares at $16 per share.
The offering was the largest biotech IPO, surpassing Moderna's previous record.
Proceeds will fund Kailera's obesity pipeline, including ribupatide in Phase 3.
CEO Ron Renaud said the company will focus on executing its strategy.
The IPO signals a resurgence in biotech listings after a brief slowdown.